Pomeranian Medical University Szczecin clinical trials
Pomeranian Medical University Szczecin is the lead sponsor of 10 current clinical trials in our Poland, Germany, Denmark and Czechia registers. 4 are recruiting patients now. The most common phase is Observational. The drugs named most often in its trials are Cabotegravir and Ceftriaxone. The most-studied condition is Cancer.
ClinicalTrials.gov trials by status
Trials by phase
Clinical trials sponsored by Pomeranian Medical University Szczecin
10 on ClinicalTrials.gov| Study | Phase | Status | Start | Registers |
|---|---|---|---|---|
|
Long-Acting Cabotegravir and Rilpivirine in People Living With HIV-1 Subtype A6: A Real-World Retrospective Study
NCT07370649 · ClinicalTrials.gov ↗ · Human Immunodeficiency Virus (HIV)-1 Infection, HIV-1 Subtype A6 Infection, HIV-1 Subtype B Infection
Drug: Cabotegravir |
Observational | Recruiting | 2026-05 | Germany, Poland, Czechia |
|
Enhanced Molecular Microbiological Surveillance Versus Ceftriaxone Prophylaxis in Hematopoietic Cell Transplant Patients
NCT07308457 · ClinicalTrials.gov ↗ · Incidence of Infectious Diseases
Drug: Ceftriaxone |
Not applicable | Recruiting | 2024-09 | Poland |
|
Home Monitoring of Complete Blood Count Performed by Patients - a Pilot Study on the Implementation Process in South Baltic Countries.
NCT06809101 · ClinicalTrials.gov ↗ · Cancer, Cancer-related Problem/Condition, Chemotherapy
|
Observational | Recruiting | 2025-03 | Germany, Denmark, Poland |
|
Evaluation of Visual Outcomes, Complications, and Neuroadaptation Following Bilateral Implantation of enVista Envy Trifocal Intraocular Lenses
NCT07696130 · ClinicalTrials.gov ↗ · Cataract, Cataract (Post-operative Cataract Surgery Follow-up)
|
Not applicable | Recruiting | 2026-02 | Poland |
|
Metabolic Obesity in Normal Weight (MONW): Diagnostic Markers Stud
NCT07358533 · ClinicalTrials.gov ↗ · Normal Weight Obesity, Metabolically Obese Normal Weight, Metabolic Syndrome
|
Observational | Not yet open | 2026-09 | Poland |
|
Evaluation of Retinal Parameters in Patients With Epiretinal Membrane After Vitrectomy
NCT07165626 · ClinicalTrials.gov ↗ · Epiretinal Membrane, Macular Oedema, Macular Diseases
|
Not applicable | By invitation | 2024-05 | Poland |
|
Microanalysis of Changes in 3D Geometry of Orthodontic Mini-implants
NCT06743360 · ClinicalTrials.gov ↗ · Malocclusions, Malocclusion, Angle Class I, Malocclusion, Angle Class II
|
Observational | Active, closed | 2024-10 | Poland |
|
Predicting Operational Difficulties and Outcomes of RARP Based on Preoperative Assessment - Introducing the PIODO Questionnaire
NCT06985004 · ClinicalTrials.gov ↗ · Prostate Cancer, Robot-Assisted Laparoscopic Radical Prostatectomy
|
Observational | Active, closed | 2024-01 | Poland |
|
Epigenome-wide DNA Methylation Profiling in Aneurysmal Subarachnoid Hemorrhage and Delayed Ischemic Neurologic Deficit
NCT06881329 · ClinicalTrials.gov ↗ · Subarachnoid Hemorrhage, Aneurysmal, Delayed Cerebral Ischemia, Cerebral Vasospasm After Subarachnoid Hemorrhage
|
Observational | Active, closed | 2021-12 | Poland |
|
Sagittal Spine Balance in Patients With Chest Wall Deformity
NCT07070609 · ClinicalTrials.gov ↗ · Scoliosis Idiopathic Adolescent, Chest Deformities
|
Observational | Active, closed | 2025-03 | Poland |
Registers list studies that are recruiting, about to open, active but closed to enrolment, or enrolling by invitation. The UK and USA registers cover industry-sponsored studies only. Titles and statuses are copied from the registry as published.
Drugs in Pomeranian Medical University Szczecin trials
2 compoundsDrugs and biologicals named as interventions in these trials, with the number of this sponsor's trials that name each one. Placebos and generic comparators are excluded.
Conditions in Pomeranian Medical University Szczecin trials
29 conditionsBy trial register
| Register | Trials | Recruiting |
|---|---|---|
| Clinical trials in Poland | 10 | 4 |
| Clinical trials in Germany | 2 | 2 |
| Clinical trials in Denmark | 1 | 1 |
| Clinical trials in Czechia | 1 | 1 |
A trial with sites in more than one country appears in each of those registers.
Other sponsors in Cancer
Sponsors with the most current trials registered for this condition.
Questions about Pomeranian Medical University Szczecin trials
How many clinical trials does Pomeranian Medical University Szczecin sponsor?
Pomeranian Medical University Szczecin is the lead sponsor of 10 current trials on ClinicalTrials.gov in our Poland, Germany, Denmark and Czechia registers, as of the registry sync on 16 November 2026. Completed and withdrawn studies are not counted.
Are Pomeranian Medical University Szczecin trials recruiting?
Yes. 4 of its 10 ClinicalTrials.gov trials are recruiting. Eligibility and site contacts are on each trial's record. Only the study team can confirm whether a patient is eligible.
Which drugs is Pomeranian Medical University Szczecin testing?
Its current trials name 2 drugs and biologicals as interventions. The most frequent are Cabotegravir (1) and Ceftriaxone (1). The number in brackets is how many of its trials name each drug.
Where does this information come from?
Every trial, status, phase and condition on this page is copied from public ClinicalTrials.gov and EU CTIS records by a daily sync, grouped by the sponsor name each registry records. It says nothing about the organisation beyond its registered trials, and it is not medical advice.
How this page is built
Everything on this page is copied from public registry records — it is not written from memory, and nothing here describes the organisation beyond its registered trials. Each trial links to its own record so you can check it yourself.
- ClinicalTrials.gov (U.S. National Library of Medicine) ↗ Trial IDs, titles, lead sponsor, phase, overall status, start date, conditions and intervention names
- EU Clinical Trials Information System (CTIS) ↗ EU trial numbers, titles, sponsor, phase, status, therapeutic area and member-state countries
This page is built automatically: a daily sync job reads the registry records behind our trial registers and groups every current trial by its lead sponsor name, ignoring legal-form suffixes such as Inc. or Ltd. A small, hand-checked list joins the same organisation's different registry names (for example its EU legal entity). There is no AI drafting and no per-sponsor editorial pass. The “last verified” date above is the timestamp of that sync, not a review date. Our general editorial approach is described in our editorial standards and corrections policy. The the registries data on this page was last retrieved on 16 Nov 2026. How every register is built: methodology · fixes we have made: corrections log.